United States · FDA National Drug Code directory
Lidozall
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72835-004_436cebe5-b978-2a2f-e063-6294a90a7227
- Product NDC
- 72835-004
- Form
- CREAM
- Composition / generic term
- LIDOCAINE HYDROCHLORIDE
- Labeler
- V2 Pharma LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20241121
- Source listing expiry
- 20261231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 4 g/100g
These values do not establish equivalence or a dose recommendation.
Packages
- 20 PACKET in 1 CARTON (72835-004-20) / 2 g in 1 PACKET (72835-004-01) · 72835-004-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →